Daptomycin In Sodium Chloride recalls
Daptomycin In Sodium Chloride products have been recalled 2 times, most recently on 9 Sep 2026. The recalling company is usually Baxter Healthcare. The most common reason is sterility.
Total recalls2since 2026
Last 12 months2reported
Class I00% of total
Ongoing2latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why daptomycin in sodium chloride is recalled
Companies
Product types
By year
Ongoing daptomycin in sodium chloride recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Daptomycin, in 9% Sodium Chloride Injection, 500 mg recalledDaptomycin In Sodium Chloride | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Daptomycin, in 9% Sodium Chloride Injection, 1,000 mg recalledDaptomycin In Sodium Chloride | Baxter Healthcare | Sterility | Nationwide |
All daptomycin in sodium chloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Daptomycin, in 9% Sodium Chloride Injection, 500 mg recalledDaptomycin In Sodium Chloride | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Daptomycin, in 9% Sodium Chloride Injection, 1,000 mg recalledDaptomycin In Sodium Chloride | Baxter Healthcare | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.